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Abstract
Genetic variation modulates gene expression transcriptionally or post-transcriptionally, and
can profoundly alter an individual’s phenotype. Measuring allelic differential expression at
heterozygous loci within an individual, a phenomenon called allele-specific expression
(ASE), can assist in identifying such factors. Massively parallel DNA and RNA sequencing
and advances in bioinformatic methodologies provide an outstanding opportunity to mea-
sure ASE genome-wide. In this study, matched DNA and RNA sequencing, genotyping ar-
rays and computationally phased haplotypes were integrated to comprehensively and
conservatively quantify ASE in a single human brain and liver tissue sample. We describe a
methodological evaluation and assessment of common bioinformatic steps for ASE quantifi-
cation, and recommend a robust approach to accurately measure SNP, gene and isoform
ASE through the use of personalized haplotype genome alignment, strict alignment quality
control and intragenic SNP aggregation. Our results indicate that accurate ASE quantifica-
tion requires careful bioinformatic analyses and is adversely affected by sample specific
alignment confounders and random sampling even at moderate sequence depths. We iden-
tified multiple known and several novel ASE genes in liver, includingWDR72, DSP and
UBD, as well as genes that contained ASE SNPs with imbalance direction discordant with
haplotype phase, explainable by annotated transcript structure, suggesting isoform derived
ASE. The methods evaluated in this study will be of use to researchers performing highly
conservative quantification of ASE, and the genes and isoforms identified as ASE of interest
to researchers studying those loci.
Introduction
Amajor goal of medical genomics is linking genetics with complex traits and diseases, and one
mechanism by which genetic variability contributes to phenotype is through modulation of
PLOSONE | DOI:10.1371/journal.pone.0126911 May 12, 2015 1 / 27
a11111
OPEN ACCESS
Citation:Wood DLA, Nones K, Steptoe A, Christ A,
Harliwong I, Newell F, et al. (2015)
Recommendations for Accurate Resolution of Gene
and Isoform Allele-Specific Expression in RNA-Seq
Data. PLoS ONE 10(5): e0126911. doi:10.1371/
journal.pone.0126911
Academic Editor: I. King Jordan, Georgia Institute of
Technology, UNITED STATES
Received: February 3, 2014
Accepted: April 9, 2015
Published: May 12, 2015
Copyright: © 2015 Wood et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Funding: This research was funded under an
Australian Research Council (ARC) discovery project
grant (DP0988754). DW was supported by an
Australian Postgraduate Award funded by the
Australian Government. NC was supported by ARC
grant (DP0988754 and FT120100453). The funders
had no role in study design, data collection and
analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared
that no competing interests exist.
gene expression [1–3]. Small changes in gene expression can lead to profound phenotypic
change, and may predispose an individual to disease [4–8]. Genetic variations can modulate
transcription rate via epigenetic changes [9–12], through modification of transcription factor
binding affinity [13], or post-transcriptionally by changing splicing patterns [14–17]. An effec-
tive method to assist in the identification of cis acting genetic factors is to study allelic imbal-
anced expression at heterozygous SNPs within an individual, a phenomenon commonly
referred to as allele-specific expression (ASE). Identifying ASE can pinpoint causative and
often low frequency disease associated variants [16]. ASE is a complex phenomenon caused by
a variety of mechanisms including imprinting, X-chromosome inactivation and the above-
mentioned transcriptional and post-transcriptional acting factors (for reviews, see references
[18–20]).
Massively parallel RNA-sequencing [21,22] is well suited to study ASE as it provides nucleo-
tide-resolution data, digital quantification of allele expression and comprehensive genome-
wide coverage. Using this technology, multiple screens have been performed searching for ASE
across lymphoblastoid cell lines and primary tissues [16,17,23–25]. Studies on the frequency of
ASE genome-wide vary greatly, ranging from about 5% [26,27], to around 20% [28,29] and as
high as 80% [30]. The reasons for these differences are a combination of genetic diversity, the
tissues being studied, and also the informatics, statistics and classification of ASE, which has
been shown to be particularly challenging [26,31,32]. Accurate quantification of ASE relies on
sufficient sequence depth, sufficient heterozygosity, correct alignment with appropriate error
control mechanisms, and comprehensive integrative expression analysis.
In this study, we performed a methodological evaluation of frequently used bioinformatic
processes associated with ASE research. The method of aligning reads to personalized haplo-
type genomes [28] is confirmed in our results as highly beneficial for ASE analysis over
universal genome alignment. SNP alignments are comprehensively interrogated and recom-
mendations provided for removing SNPs from analyses that are likely to provide erroneous
ASE predictions. In addition, we explore two surprisingly overlooked areas of ASE analysis, the
affect of sampling on allele expression quantification, and concordance of allele expression im-
balance direction among intragenic phased SNPs. Finally, we apply these methods to catalog
ASE events in two human tissues, show how this method can identify known and novel ASE
genes, and propose that the much of ASE we observe in these data is isoform-specific and most
likely driven by complex transcriptional events, of which novel examples are provided.
Results and Discussion
Generation of a high-resolution, customized data set for ASE
identification
To robustly interrogate the biases associated with ASE identification, we have generated high-
resolution, high-quality data consisting of; (i) two technical replicates of total RNA sequencing
(RNA-seq) from two human tissue samples with an average of 96.96 million uniquely mapped
reads per sample; (ii) whole genome sequencing (WGS) from the same samples with an average
coverage of 24.44, and (iii) matching genotyping arrays using the Illumina Omni Quad 1 mil-
lion SNP chips.
Within a single sample, the power to detect ASE is determined by the number of sufficiently
expressed heterozygous SNPs [16], and improved by incorporating haplotype phase informa-
tion [30,33]. To maximize this power, we called SNPs fromWGS data for each individual, then
phased haplotypes using a subset of these SNPs independently verified by array genotyping
(see Materials and Methods). This approach resulted in 10.27 and 10.29 million phased and se-
quence verified SNPs for the liver and brain samples respectively, of which 1.63 and 1.65
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million were heterozygous and available for ASE testing if expressed (S1 Table). The propor-
tion of heterozygosity of WGS verified SNPs in brain and liver was 16.03% and 15.86%, respec-
tively (S1 Fig). These proportions were consistent (slightly lower than the mean) with all
samples from the 1000G reference data set used for imputation. Performing both the SNP im-
putation and WGS provided a robust and comprehensive set of variants with which to evaluate
ASE, more than six times the coverage of the genotype array. Obtaining the haplotype phase
provided a framework on which to assist in reconstructing observed isoform-specific ASE
events.
A small proportion of SNPs called from the WGS data were not present in the haplotype
reference set (453,562 from brain and 423,364 from liver), and were excluded from ASE testing
as they could not be phased. Additionally, 160,844 and 221,595 small insertions and deletions
(indels) were called in the liver and brain samples respectively. Both these and the un-phased
SNPs were utilized when interrogating alignment accuracy (see below).
Diploid alignment improves sensitivity and specificity of SNP ASE
classification
Previous studies have shown that aligning RNA-seq reads to personalised haplotype genomes
and selecting the best alignments (hereon referred to as ‘diploid alignment’) largely eliminates
‘reference bias’ seen when aligning reads to the universal reference (‘universal alignment’)
[26,28]. However, several recent studies have not adopted this methodology, instead relying on
simulation studies to exclude SNPs identified as affected by reference bias [16,17]. We tested
the effectiveness of diploid alignment, constructing personalized haplotype genome sequences
for each individual from the phased high-confidence SNPs, against which we aligned the RNA-
seq data. An optimal set of alignments was selected and written to BAM files using custom soft-
ware available on request (see Materials and Methods). The resulting mapped data sets con-
tained between 16.09 and 25.69 million PCR de-duplicated, uniquely aligned R1 reads (S2
Table). Gene expression values between library replicates showed strong technical reproduc-
ibility (S2 Fig).
To quantify the difference between diploid and universal alignment methods, we compared
the number and allelic origin of reads aligning to high-confidence heterozygous SNPs. At SNPs
with at least 10 uniquely mapped, PCR de-duplicated reads (referred to from here as ‘testable
SNPs’), diploid alignment resulted in an additional 177,618 reads uniquely aligning (4.7% of all
reads aligning across heterozygous SNPs, S3 Table). Of these additional reads, the vast majority
(77.3%), were RNA transcribed from the variant allele. Diploid alignment resulted in a mean
reference fraction of 0.503, much closer to the expected fraction of 0.5 and significantly differ-
ent to universal alignment (mean reference fraction 0.516, p-value< 4.21e-77, student t-test,
S3 Fig). Therefore, diploid alignment resulted in increased data yield, most of which was vari-
ant derived, and more balanced allelic expression, consistent with previous observations
[26,28].
Allelic expression imbalance is a quantitative not qualitative trait, but in order to survey it
across tissues, we categorized each SNP as ASE or not using both the observed reference frac-
tion and the probability of this reference fraction (see Materials and Methods for details).
Using both criteria ensured that neither highly expressed SNPs with slight imbalance, nor
lowly expressed SNPs with large imbalance were classified as ASE, resulting in a conservative
set of ASE SNPs. In total, more SNPs were classified ASE using universal alignment (8.76%;
8,082 out of 92,250) than diploid alignment (7.45%; 7,177 out of 96,658; S4 Table). For SNPs
that were testable in both methods (n = 92,235), 23.25% changed reference fraction between
the diploid and universal alignment sets, indicating that at least one alignment at those loci
ASE in Human Brain and Liver
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differed between the methods. More than two percent of SNPs showed substantial enough ref-
erence fraction changes to force an ASE reclassification, resulting in 344 more ASE SNPs and
1,620 less ASE SNPs in the diploid alignment set compared to the universal alignment set (Fig
1). These results indicate that not only did diploid alignment reduce global reference bias, but
it had the highly desirable effect of increasing the number of testable SNPs (higher sensitivity),
and reducing the extent of alignment bias and therefore false positive ASE classifications
(higher specificity).
Proximal SNVs and poor alignability cause false positive ASE
predictions
Small insertions and deletions (indels) and SNPs, collectively termed small nucleotide varia-
tions (SNVs) not included in the construction of the personalised haplotype references may
cause additional alignment errors and false positive ASE calls. To evaluate the extent of this,
SNPs were binned by the genomic distance to their nearest un-phased SNV and the proportion
of ASE SNPs in each bin calculated. SNPs with an indel very close (less than 10bp) were much
more likely to be classified ASE (32.63% of SNPs, n = 95, Fig 2a) than the average likelihood of
7.43%. Extending further, all SNPs within the length of a read (100bp) of an un-phased SNV
were more likely to be classified as ASE than SNPs with distal indels. SNPs with proximal un-
phased de novo called SNPs were less affected, and only displayed a marginal increase above av-
erage ASE classification proportion (Fig 2b). SNPs with multiple other SNPs in close proximity,
however, displayed greater likelihood of ASE classification (Fig 2c). These results are consistent
with recently reported analyses showing an increased proportion of ASE SNPs proximal to
SNVs [16,32]. However, in addition to this, we also observed an increase in positive ASE classi-
fication for SNPs located up to 10kb from SNVs (S4 Fig). This observation may be due to
spliced reads spanning larger genomic distances and therefore distal error causing SNVs, or ev-
idence of increased ASE in polymorphic regions, possible given expression quantitative trait
loci (eQTLs) can be causative of cis expression modulation up to 2Mb away from their target
genes [34].
In addition to assessing alignment artifacts, we also quantified the affect read alignability
had on SNP ASE classification. Due to sequence similarity, some genomic regions are more dif-
ficult to align than others [35,36], and reads derived from these regions are more likely to map
incorrectly. In such regions, if alignment errors occur, we expect a higher number of false posi-
tive ASE predictions. To test this, we calculated the proportion of ASE SNPs binned by align-
ability values obtained from the Encode 100bp alignability track [36]. SNPs with lower than
perfect alignability (<1) showed a higher likelihood of being classified as ASE than SNPs with
perfect alignability (Fig 2d), suggesting that these SNPs were likely subject to erroneous ASE
predictions caused by incorrect or missing alignments.
Taken together, these SNP alignment tests provided a comprehensive assessment of the sus-
ceptibility of our ASE predictions to alignment error. Very few SNPs were affected by more
than one alignment confounder, and surprisingly SNPs with the largest changes in reference
fraction between diploid and universal alignment methods were mostly unaffected by these po-
tential alignment error causing artifacts (S5 Fig). These results indicate that comprehensive
alignment quality control, in addition to the diploid alignment method, is highly desirable to
improve the coverage and accuracy of ASE predictions and should be adopted when possible.
To obtain a high confidence set of SNPs for further analysis, we used the diploid alignments,
and removed SNPs with either an indel or four or more un-phased SNPs within 100bp, as well
as SNPs with less-than-perfect alignability. Across both tissues, 1,177, 397 and 923 SNPs fell
into each of these categories respectively. In total, 2,450 SNPs testable for ASE were removed
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(1,000 from the brain sample, and 1,450 from liver, S5 Table). Full tables of all testable SNPs
across all replicates are provided in S1 Dataset.
Low R2 values do not substantially confound ASE prediction
Although our use of WGS for SNP verification meant that it was unnecessary to rely on R2 val-
ues as a measure of imputation quality, we did observe an increase in the proportion of ASE
called SNPs with lower R2 values (from 6.9% when R2> 0.9 to 21.8% when R2< 0.2, S6a Fig).
It was therefore important to more closely examine the R2 values of our imputed SNPs to ex-
clude a potential source of bias in our results. As might be expected, SNPs with the lowest
Fig 1. SNP reference fraction correlations between universal and diploid alignment methods. Each point is a SNP, coloured according to its ASE
classification in both alignment methods. Bar plots indicate the proportion of all SNPs in the plot (left), and the proportion of all SNPs classified as ASE in any
method (right). Aligning RNA-seq reads to personalised haplotype references then choosing the alignments with the smallest edit-distance resulted in more
balanced allelic expression ratios than aligning to the universal reference.
doi:10.1371/journal.pone.0126911.g001
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R2 values (<0.1) made up the majority of the SNPs failing WGS verification (314,995 of
675,687 in total), however SNPs across the entire range of R2 values failed verification, includ-
ing 98,163 SNPs with R2 values 0.9 (S6c Fig). Proportionally, SNPs with high R2 values had
the highest WGS verification rate (S6d Fig). SNPs with low R2 values were proportionally
Fig 2. SNPs proximal to SNVs are more likely to be ASE. (A) SNPs binned by genomic distance to nearest heterozygous indel. (B) SNPs binned by
nearest heterozygous un-phased de novo called SNP. (C) SNPs binned by the number of proximal heterozygous SNPs. (D) SNPs binned by genomic
alignability. The closer a SNP is to a heterozygous SNV, the more likely that SNP is to be classified as ASE. For indels, this effect is stronger than SNPs,
which are only slightly affected, however as the number of SNPs within a read length (100bp) increases, this effect is increased. In all plots, the dashed line
represents the average ASE proportion for all SNPs. Numbers at the top of the bars indicate the number of SNPs in each bin (blue not ASE, red ASE).
doi:10.1371/journal.pone.0126911.g002
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depleted of both WGS failed andWGS verified heterozygous SNPs relative to SNPs with higher
R2 values (S6e and S6f Fig).
Looking specifically at SNPs imputed as heterozygous, the observed fraction of reads match-
ing the reference allele at these SNPs for all SNPs passing WGS verification were centered
around 0.5, a result consistent with genuine heterozygosity (S7a Fig). SNPs failing verification
have reference fractions mostly around 1.0 or 0.0, and are most likely homozygous SNPs incor-
rectly called heterozygous (S7b Fig). We note an enrichment for SNPs with R2 values of 1.0,
but DNA reference fractions of around 0.8 or 0.2 as failing WGS verification (S7b Fig). Many
of these SNPs are most likely heterozygous, but excluded from our analysis due to insufficient
coverage for statistically reliable SNP calling. We next plotted the correlation between R2 values
and the RNA-seq reference fraction for all testable SNPs. No specific bias towards low R2 values
was observed—SNPs with low R2 values show the same range of reference fraction values than
SNPs with high R2 values (S7c Fig).
Finally, we re-plotted the proportion of ASE called SNPs after filtering for proximal SNVs
and poor alignability (see previous section), and found that the bias towards low R2 values was
substantially reduced (from 21.8% to 11.4% when R2< 0.2, S6b Fig). As there was still a small
bias, we repeated the analyses investigating the proportion of ASE SNPs proximal to SNVs and
within specific transcript features using only perfect proxies (R2 = 1) to determine whether the
inclusion of SNPs with a lower R2 value has confounded our results. The proportions of SNPs
classified as ASE reduced for those proximal to SNVs and in regions of poor alignability, but all
proportions were still above the average ASE rate genome-wide (S8 and S9 Figs). These results
show that even when using SNPs with perfect R2 values, alignment confounders still affect ASE
quantification and SNPs proximal to such confounders should be removed. Together, these re-
sults confirm that WGS verification and subsequent filtering of imputed SNPs allows for a sen-
sitive examination of ASE without substantial bias from the inclusion of SNPs with low
R2 values.
Sampling Confounds ASE Prediction
Previous studies have relied on testing ASE at SNPs using depths as shallow as six reads [28]
but routinely at a depth of 20 [27,29]. At these depths, ASE quantification is susceptible to sub-
stantial sampling variability causing skewed reference fraction predictions (S10 Fig). Sampling
effects in this study were quantified by comparing ASE SNP classifications between technical
replicates. Of all pairs of testable SNPs, 86.39% were classified as not ASE in both replicates. Of
the remaining 13.61%, 18.24% were classified as ASE in both replicates (2.48% of all SNPs,
from here referred to as ‘replicated ASE SNPs’, Fig 3 and S6 Table). The remaining SNPs were
split relatively evenly between replicates (38.92% classified as ASE in replicate one and 42.84%
in replicate two). While the reference fractions and ASE classification of SNPs were not strong-
ly correlated across these data, the sequence depth measured at each of these testable SNPs was
strongly correlated (S11 Fig).
We next tested whether increasing the minimum read depth to test a SNP for ASE would
improve correlations between replicates. Setting the minimum read depth to 50 reads increased
the overlap of ASE SNP classifications to 40.80%, and raising it to 100 or more reads increased
the overlap to 65.15%, but resulted in a massive loss of testable SNPs (from 30,762 at 10
+ reads, to 1,868 at 100+ reads, S6 Table and S12 Fig), representing an unacceptable loss of test-
able SNPs. Sampling effects on allele expression is even greater than sampling effects for bialle-
lic gene and isoform expression due to the second degree of freedom introduced by the
additional variable (allele) to be tested, and because on average the actual amount of data avail-
able for allele expression quantification is half that for gene expression quantification. These
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results indicate that sampling can be a major confounder in ASE quantification, even at moder-
ate depths, and render important the use of SNP aggregation methods (described below), repli-
cation or independent verification when measuring ASE.
SNP aggregation by phased haplotype reduces sampling affects
Having collated a high confidence set of replicated and alignment quality controlled SNPs, we
next sought to evaluate the extent of ASE at a whole-locus level by SNP aggregation. All testable
and alignment quality controlled SNPs within annotated Ensembl v71 genic boundaries were
collated and genic ASE calculated using a binomial test on the sum of the haplotype read
counts. This method accommodates sampling effects observed at individual SNPs as the
Fig 3. Reference fraction correlations between replicates using diploid alignment. Each point is a SNP, coloured according to its ASE classification in
both replicates. Bar plots indicate the proportions of all SNPs in the plot (left), and ASE SNPs (right). Calculating ASE with low read counts can result in
sampling being a confounder.
doi:10.1371/journal.pone.0126911.g003
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summed counts have substantially more power, as well as quantifies allelic imbalance with re-
spect to haplotype, and provides a mechanism to rank ASE genes by magnitude of imbalance.
Each gene was annotated with the presence of multiple testable exonic SNPs, replicated ASE
SNPs, and concordant direction of allelic imbalance with the phased haplotype. Taken togeth-
er, genes could then be ranked and interrogated for maximum accuracy or sensitivity.
Across both tissues, of the 3,843 genes with at least two testable exonic SNPs in both repli-
cates, 143 contained at least one replicated ASE SNP, and all SNPs showed concordant imbal-
ance direction in 43 of these (S1 Dataset). Ensuring a gene contained at least one replicated
ASE SNP dramatically increased the overlap of ASE genes between technical replicates and
hence the specificity of our candidate lists (S13 Fig). However, removing this imbalance con-
cordance requirement increased the number of genes classified as ASE in both replicates from
69.1% to 73.2%. This is to be expected, as sampling variability will affect SNPs causing the alle-
lic fraction to skew and hence the test for phase concordance is not as robust as the genic test
of ASE. This observation is also biologically meaningful, as genetic differences have been
shown to differentially affect intragenic exon expression [16]. We note also that of all SNPs
testable in both replicates (n = 30,762), 13.47% were testable in both tissues (n = 2,072 for each
tissue). Of these SNPs, only eight were classified as ASE in both liver and brain, possibly indi-
cating high tissue-specificity for ASE SNPs (S14 Fig).
A recommendation on methodology for ASE quantification
As described above, quantification of ASE using RNA-seq data can involve a series of bioinfor-
matic steps not typically performed when quantifying standard gene or isoform expression.
These include nucleotide specific integration of genotype and haplotype phase data with RNA-
seq, personalised sequence alignment [26,28], alignment quality control [32], and intragenic
SNP aggregation [30] (Fig 4). Performing all of these steps will provide a robust and conserva-
tive set of putative ASE SNPs and genomic regions (genes, isoforms or regions). When sample
sizes are small, and high specificity is required for ASE analyses, we suggest using all of these
methods. The following sections describe the genes and isoforms identified as ASE in the liver
and brain samples.
Description of known and novel ASE genes
The two tissues in this study were selected for the high frequency of imprinting in brain (re-
viewed in [37]), and the high amount of known genetic modulation of gene expression within
metabolically active liver [38]. The 40 genes showing the strongest evidence for ASE are shown
in Fig 5 and Table 1 and Table 2. Our method is confirmed by identification of known im-
printed genes among the top ASE brain genes (PEG3, PEG10, INPP5F,MEG3, IGF2), and also
in liver (MEG3). Imbalanced expression was also detected in liver at the ERAP2 locus, which
harbors a known splicing quantitative trait loci (sQTL) introducing a premature stop codon,
resulting in allele-specific nonsense mediated decay [39] (S15a Fig). Our assay detected the
gene GSTA2 with very strong ASE in liver (S15b Fig). GSTA2 is highly expressed in this tissue,
and has well characterised genetically modulated expression variability that affects an individu-
als ability to detoxify carcinogen metabolites and efficacy to chemotherapeutic drugs [40].
Investigation of the remaining highly imbalanced genes in liver identified several other can-
didates showing near monoallelic expression (Fig 6). These included Desmoplakin (DSP), im-
plicated in skin fragility, wooly hair syndrome [41] and heart disease [42], WD repeat domain
72 (WDR72) an uncharacterized tissue-restricted beta-propeller protein implicated in the
tooth enamel disorder hypomaturation amelogenesis imperfecta [43], and Ubiquitin D (UBD)
a broadly expressed ubiquitin-like protein necessary for protein degradation in which a single
ASE in Human Brain and Liver
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polymorphism linked to celiac disease [44]. Of these three genes, none have any described
eQTLs in liver tissue in the eQTL Browser (http://eqtl.uchicago.edu/cgi-bin/gbrowse/eqtl/) da-
tabases (Table 2). Given the strength of ASE observed for these genes, any functional conse-
quence in liver tissue deserves further investigation.
Discordant direction of ASE SNP imbalance explained by splicing
patterns
While there are several examples of genes with SNPs showing strong concordant direction of
imbalance in these data, multiple examples exist of genes containing strong ASE SNPs with dis-
cordant direction of imbalance (Fig 5). Given recent evidence showing that much ASE in lym-
phoblastoid cells is isoform derived [16], and the very high confidence we have that our
observed ASE SNPs are real and not sequencing artifacts, we hypothesized that the discordant
SNP allelic imbalance we observed in our data derived from allele-specific isoform regulation.
In order to explore this, we began by quantifying the proportion of ASE SNPs predicted in
different transcript features. We labeled every testable SNP as one or more of the following;
coding exonic, intronic, 3’UTR, 5’UTR and intergenic. Using these classifications, 72,321 out
of 96,658 (74.82%) testable SNPs were annotated with a single transcript feature type and re-
tained for further analysis (SNPs overlapping multiple features were discarded). Calculating
the proportion of ASE SNPs for each transcript feature, we found a higher proportion of SNPs
classified as ASE in intergenic regions (8.21%, p-value< 0.005) than the average proportion of
Fig 4. Recommended workflow for ASE quantification usingmatched genotype and RNA-seq data.Robust quantification of ASE requires detailed
genotype information and matched high quality RNA-seq data. Phasing and imputing SNPs provides haplotype information, used to determine whether
intragenic SNPs with imbalanced expression show concordant direction of imbalance, as well as build personalised reference genomes for alignment.
Personalised alignment increases both sensitivity (data yield) and specificity of ASE quantification. WGS data can be used to identify indels and other
proximal SNVs not included in the imputation reference data set that may confound alignment and potentially produce false positive ASE calls. SNPs
proximal to such factors can be removed from further analysis. Aggregation of SNPs by gene and isoform boundaries reduces potential sampling issues for
lowly expressed regions, and assists in identifying ASE regions (genes and isoforms).
doi:10.1371/journal.pone.0126911.g004
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Fig 5. Highest ranked ASE genes from (A) brain and (B) liver. Each gene is shown as vertical bars of exonic SNPs testable within that gene. Red boxes
are imbalanced towards haplotype A, and blue boxes imbalanced towards haplotype B, darker colours indicate more significant the level of imbalance. All
data presented is the average of the two replicates. Genes are ordered left to right by the probability of gene imbalance. Stars below the bars indicate
whether the gene is known imprinted (red), or whether the SNPs for that gene all show concordant direction of expression imbalance in each replicate
(black). Each of the tissues has a cluster of genes with very significant SNPs mostly with concordant direction of ASE towards the left of the plots (strong
genic ASE). It is clear, however, that some genes contain SNPs that vary in their direction and magnitude of imbalance.
doi:10.1371/journal.pone.0126911.g005
ASE in Human Brain and Liver
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Table 1. Top ASE genes from the brain tissue sample.
Ensembl Gene ID Gene Name Imbalance
P-value
Rep1 In-
phase
Rep2 In-
phase
Imprinting
Statusa
eQTLsb transcript-
QTLsb
exon-
QTLsb
ENSG00000198825 INPP5F 0 YES YES Paternal 0 0 0
ENSG00000257151 RP11-701H24.2 0 YES YES Not reported 0 0 0
ENSG00000198300 PEG3 4.94E-324 YES YES Paternal 0 0 0
ENSG00000242265 PEG10 2.16E-211 YES YES Paternal 0 0 0
ENSG00000233927 RPS28 3.40E-168 YES YES Not reported 1 0 0
ENSG00000214548 MEG3 5.32E-110 YES YES Maternal 21 0 0
ENSG00000133114 KIAA1704 5.25E-44 YES YES Not reported 3 0 1
ENSG00000125648 SLC25A23 1.46E-30 YES YES Not reported 2 0 0
ENSG00000100376 FAM118A 4.63E-30 YES No Not reported 67 0 0
ENSG00000084453 SLCO1A2 9.30E-28 No No Not reported 0 0 0
ENSG00000171130 ATP6V0E2 1.94E-25 YES YES Not reported 1 0 0
ENSG00000006715 VPS41 5.80E-21 No YES Not reported 33 0 4
ENSG00000186340 THBS2 6.24E-17 YES No Not reported 0 0 0
ENSG00000167244 IGF2 1.40E-15 YES YES Paternal 1 0 0
ENSG00000160352 ZNF714 6.24E-13 YES YES Not reported 0 0 0
ENSG00000112584 FAM120B 9.85E-10 No YES Not reported 1 1 0
ENSG00000148671 C10orf116 2.40E-08 YES YES Not reported 2 0 0
ENSG00000151303 AGAP11 2.40E-08 YES YES Not reported 0 0 0
ENSG00000136235 GPNMB 2.08E-07 YES YES Not reported 53 0 0
ENSG00000215447 BX322557.10 4.59E-07 YES YES Not reported 0 0 0
ENSG00000198794 SCAMP5 5.17E-07 No No Not reported 29 0 0
ENSG00000066427 ATXN3 7.13E-07 No No Not reported 23 0 0
ENSG00000250366 LINC00617 7.51E-06 No No Not reported 0 0 0
ENSG00000013297 CLDN11 7.87E-06 YES YES Not reported 1 0 0
ENSG00000232229 RP11-248C1.2 1.07E-05 No No Not reported 0 0 0
ENSG00000258289 CHURC1 1.07E-05 No No Not reported 133 0 0
ENSG00000247828 TMEM161B-AS1 2.47E-05 No YES Not reported 0 0 0
ENSG00000197016 ZNF470 9.58E-05 YES No Not reported 0 0 0
ENSG00000118276 B4GALT6 2.22E-04 No YES Not reported 0 0 0
ENSG00000123983 ACSL3 3.82E-04 YES No Not reported 8 0 3
ENSG00000126878 AIF1L 4.17E-04 YES YES Not reported 0 0 0
ENSG00000150054 MPP7 8.60E-04 No No Not reported 0 0 0
ENSG00000162636 FAM102B 1.12E-03 No No Not reported 0 0 0
ENSG00000074603 DPP8 1.96E-03 No No Not reported 0 0 5
ENSG00000170500 LONRF2 6.12E-03 No No Not reported 0 0 0
ENSG00000163624 CDS1 1.41E-02 YES YES Not reported 0 0 0
ENSG00000123268 ATF1 2.05E-02 No YES Not reported 0 0 0
ENSG00000162433 AK4 2.08E-02 No No Not reported 0 0 0
ENSG00000067057 PFKP 2.62E-02 No No Not reported 10 1 5
ENSG00000154654 NCAM2 3.47E-02 No No Not reported 0 0 0
a Imprinting status sourced from http://www.geneimprint.org/ accessed December 4, 2013.
b eQTL, transcript-QTL and exon-QTL data sourced from http://eqtl.uchicago.edu/cgi-bin/gbrowse/eqtl/, accessed January 29, 2014.
doi:10.1371/journal.pone.0126911.t001
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Table 2. Top ASE genes from the liver tissue sample.
Ensembl Gene ID Gene Name Imbalance
P-value
Rep1 In-
phase
Rep2 In-
phase
Imprinting
Statusa
eQTLsb transcript-
QTLsb
exon-
QTLsb
ENSG00000244067 GSTA2 0 Yes Yes Not Reported 15 0 0
ENSG00000248144 ADH1C 1.73E-186 No No Not Reported 0 0 0
ENSG00000166415 WDR72 4.47E-162 Yes Yes Not Reported 0 0 0
ENSG00000096696 DSP 9.58E-153 Yes Yes Not Reported 0 0 0
ENSG00000164308 ERAP2 3.34E-145 Yes Yes Not Reported 5 47 50
ENSG00000184999 SLC22A10 5.86E-105 Yes Yes Not Reported 1 0 0
ENSG00000204681 GABBR1 5.70E-75 Yes Yes Not Reported 0 0 0
ENSG00000213886 UBD 5.70E-75 Yes Yes Not Reported 1 0 0
ENSG00000156222 SLC28A1 2.10E-67 Yes Yes Not Reported 0 0 0
ENSG00000187824 TMEM220 3.65E-41 No Yes Not Reported 1 0 0
ENSG00000197408 CYP2B6 3.88E-40 No No Not Reported 0 0 0
ENSG00000066813 ACSM2B 6.32E-32 No No Not Reported 0 0 0
ENSG00000178104 PDE4DIP 1.05E-31 Yes Yes Not Reported 0 0 0
ENSG00000172955 ADH6 2.04E-27 No No Not Reported 0 0 0
ENSG00000137801 THBS1 1.07E-26 Yes Yes Not Reported 9 0 0
ENSG00000116785 CFHR3 8.13E-22 No No Not Reported 0 0 0
ENSG00000134962 KLB 8.24E-21 Yes Yes Not Reported 2 0 0
ENSG00000124588 NQO2 2.00E-16 Yes Yes Not Reported 49 0 0
ENSG00000205978 NYNRIN 4.96E-16 Yes Yes Not Reported 0 0 0
ENSG00000183255 PTTG1IP 2.06E-15 Yes Yes Not Reported 23 0 0
ENSG00000165272 AQP3 3.90E-14 No Yes Not Reported 1 0 0
ENSG00000214078 CPNE1 7.05E-13 Yes Yes Not Reported 167 23 46
ENSG00000214548 MEG3 1.53E-12 No No Maternal 21 0 0
ENSG00000182093 WRB 1.09E-11 Yes Yes Not Reported 38 0 0
ENSG00000112494 UNC93A 9.07E-11 Yes Yes Not Reported 0 0 0
ENSG00000243818 RP11-
372E1.4
1.30E-10 Yes No Not Reported 0 0 0
ENSG00000234745 HLA-B 2.16E-10 No No Not Reported 11 0 0
ENSG00000173193 PARP14 1.90E-09 No No Not Reported 1 0 0
ENSG00000034152 MAP2K3 4.57E-09 No No Not Reported 0 0 0
ENSG00000151470 C4orf33 8.88E-09 No Yes Not Reported 2 0 0
ENSG00000204435 CSNK2B 2.81E-08 Yes Yes Not Reported 8 0 0
ENSG00000116977 LGALS8 5.35E-08 No No Not Reported 25 0 0
ENSG00000136868 SLC31A1 2.25E-07 No Yes Not Reported 1 0 0
ENSG00000110455 ACCS 2.45E-07 Yes Yes Not Reported 3 0 0
ENSG00000124783 SSR1 4.30E-07 No No Not Reported 1 0 0
ENSG00000144115 THNSL2 4.76E-07 Yes Yes Not Reported 3 0 0
ENSG00000162836 ACP6 9.70E-07 Yes Yes Not Reported 9 0 0
ENSG00000174718 KIAA1551 4.49E-06 No Yes Not Reported 0 0 0
ENSG00000184402 SS18L1 5.66E-06 No No Not Reported 1 0 0
ENSG00000114850 SSR3 3.84E-05 Yes No Not Reported 3 0 0
a Imprinting status sourced from http://www.geneimprint.org/ accessed December 4, 2013.
b eQTL, transcript-QTL and exon-QTL data sourced from http://eqtl.uchicago.edu/cgi-bin/gbrowse/eqtl/, accessed January 29, 2014.
doi:10.1371/journal.pone.0126911.t002
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Fig 6. Schematic representation of three novel ASE genes in liver tissue. Red circles are exonic SNPs, blue circles intronic SNPs. SNP colour is
proportional to probability of ASE (darker is more significant). Error bars represent the 95% binomial confidence interval (Pearson-Klopper). The gene model
at the top shows the exonic (red) and intronic (blue) SNPs, the black sticks above these represent the read depth (minimum height represents 10 reads,
maximum height 200 or more reads). Isoformmodels below are ordered by expression (top highest), and coloured by expression (darker is higher
expressed). Only exonic SNPs are shown on transcripts, and only transcripts with at least one testable exonic SNP are drawn. Exon lengths are drawn at
log2, and intron lengths at log10. Desmoplakin (DSP) is shown in panel (A), WD Repeat Domain 72 (WDR72) in panel (B) and Ubiquitin D (UBD) in panel (C).
All three genes contain multiple imbalanced SNPs concordant with haplotype phase, indicating strong ASE. Multiple intronic SNPs were testable inWDR72
and also show strong imbalance, suggesting that this gene was likely transcribed from a single allele. As no intronic SNPs were testable in either DSP or
UBD, we cannot determine in these cases whether these genes were subject to allele-specific transcription or allele-specific post-transcriptional regulation.
doi:10.1371/journal.pone.0126911.g006
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ASE SNPs residing in a single transcript feature type only (7.43%, Fig 7). ASE SNPs expressed
in introns were significantly under-represented amongst all ASE SNPs (6.65%, p-
value< 0.004). SNPs expressed in coding regions and 3’UTRs showed slightly less ASE SNPs
than the average proportion but were not significantly different. Removing SNPs with less than
perfect imputation R2 values did not substantially change these proportions (S16 Fig). The
higher proportion of ASE SNPs in intergenic regions is most likely due to multiple SNPs locat-
ed in the brain imprinted region spanning SNURF-SNRPN and UBE3A at chromosome 15q11-
15q13, many of which have no genic annotation. The lower proportion of intronic ASE SNPs
is most likely due to the lower expression of these SNPs and hence their lower power for
ASE detection.
Having quantified ASE rates for different transcript features but not identifying strong en-
richment, we inspected all genes with ASE SNPs individually for putative isoform ASE. Several
examples of genes where SNP allelic imbalance varied considerably across the length of the
gene were observed, and may be explainable by splicing patterns (Fig 8). Complement factor
H-related 3 (CFHR3) is a liver-specific secreted protein believed to function as an inhibitor of
C3 convertase activity [45]. The CFHR3 locus in liver showed slight allelic imbalance for two
highly expressed isoforms; CFHR3-001 towards haplotype A, and CFHR3-003 towards haplo-
type B, and an intronic SNP ASE pattern suggestive of allele-specific transcription (Fig 8a).
LGALS8 (lectin galactoside-binding soluble 8) is ubiquitously expressed protein-coding gene
implicated in essential cellular functions. In the liver sample, multiple isoforms from this locus
were expressed, of which LGALS8-009 showed imbalance expression towards haplotype A (Fig
8b), the pattern of which suggests allele-specific splicing. Finally, in the brain sample, alterna-
tive splicing resulted in two isoforms expressed from the SLCO1A2 locus, suggesting allele-
specific alternate 3’UTR expression (Fig 8c). This gene expresses an organic anion-transporting
Fig 7. Proportion of SNPs annotated within transcript features categorised as ASE. Dashed black line
represents the average proportion of all ASE SNPs. SNPs falling within intergenic regions (p < 0.005) are
more likely to be classified ASE than SNPs falling in other regions. This observation is most likely due to the
high amount of imprinted SNPs in the brain sample that do not have genic annotations.
doi:10.1371/journal.pone.0126911.g007
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Fig 8. Putative allele-specific isoform expression.Red circles are exonic SNPs, blue circles intronic
SNPs, gray circles are filtered SNPs (either poor alignability or SNV proximity). SNP colour is proportional to
probability of ASE (darker is more significant). Error bars represent the 95% binomial confidence interval
(Pearson-Klopper). The gene model at the top shows the exonic (red) and intronic (blue) SNPs, the black
sticks above these represent the read depth (min height represents 10 reads, max height 200 or more reads).
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polypeptide almost exclusively in the brain, a tissue where variable use of alternative 3’UTRs
has been shown to control RNA subcellular localisation [46].
In addition to putative isoform ASE, we also observed intragenic and antisense ASE. In the
liver sample, expression of the small, uncharacterized protein-coding gene RP11-422N16.3 ini-
tiated antisense to the third exon of Syntabulin and continued downstream for over 50kb. A
large portion of this expression was detected as ASE, with 36 SNPs showing concordant direc-
tion of expression imbalance across a 14kb window (S17 Fig). In a second example, we ob-
served antisense allele-specific expression that initiated downstream of the dihydroorotate
dehydrogenase (DHODH) gene and proceeded for approximately 32kb (S18 Fig). These exam-
ples and the ones discussed previously indicate that interrogation of observed ASE SNPs re-
quires additional integrative isoform expression analysis, and can potentially explain much
intragenic SNP allelic imbalanced expression.
Conclusions
In this study we performed a methodological review of bioinformatic processes for ASE quanti-
fication, made recommendations on best-practice approaches, and used these to survey SNP,
gene and isoform ASE in two human tissue samples. Utilising genotyped, imputed and de
novo-called SNPs from whole genome data maximised heterozygous locations and subsequent
power to detect ASE across genes and isoforms, which we linked by computationally phased
haplotypes. We confirm the diploid alignment method originally proposed in reference [28] as
superior to universal alignment when quantifying ASE at the SNP level, as it increases sensitivi-
ty and specificity, and more accurately quantifies allelic expression. This method is preferable
over simulation studies as it increases the data yield, testable SNPs and hence ASE discovery
potential. SNPs with proximal SNVs were shown to be more likely to be detected as ASE, con-
firming recent analyses [32], and were therefore excluded from our analysis. Such SNPs were
shown to be largely exclusive of SNPs with variable reference fraction differences between the
diploid and universal alignment methods, indicating that both personalized alignment and
SNP quality control are necessary for robust ASE predictions with high specificity. We estimate
the SNP ASE rate in these samples to be between 2–3%, and whole gene ASE to be quite rare
(restricted to a handful of genes, mostly imprinted), with the majority of observed ASE result-
ing from complex transcriptional events, including allele-specific transcription, splicing, anti-
sense expression and 3’ UTR usage. The identification of multiple novel ASE genes and
isoforms here should prove informative for future studies exploring the functional conse-
quences of genetically linked expression variability.
Isoformmodels below are ordered by expression (top highest), and coloured by expression (darker is higher
expressed). Only exonic SNPs are shown on transcripts, and only transcripts with at least one testable exonic
SNP are drawn. Exon lengths are drawn at log2, and intron lengths at log10. (A) At the CFHR3 locus in the
liver sample, two SNPs flanking either end of the gene show high allele A expression, three of which are
specific to isoformCFHR3-001. Five SNPs show lower allele A expression in the fifth exon, and are specific to
isoformCFHR3-005. The intronic SNPs show skewed expression towards allele B, and suggest allele-
specific transcription. Taken together, these data suggest that both isoforms CFHR3-001 andCFHR3-003
are ASE, even though the gene as a whole does not show evidence of ASE. (B) In the liver sample, the
ubiquitously expressed gene LGALS8 shows isoform specific ASE from transcript LGALS8-009 (towards
allele A), whereas isoform LGALS8-001 shows balanced expression. (C) SLCO1A2 is a brain specific anion-
transporting polypeptide, and in our brain sample it expresses two isoforms testable for ASE. Both isoforms
overlap specific SNPs that show imbalanced allelic expression in opposite directions in their respective
3’UTRs. Isoform SLCO1A2-202 appears imbalanced towards haplotype B, and isoform SLCO1A2-004
towards haplotype A.
doi:10.1371/journal.pone.0126911.g008
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Materials and Methods
Ethics Statement
RNA and DNA samples for this study were purchased commercially and no ethical approval
was required.
Sample Acquisition
Human RNA and DNA from two different individuals were sourced from BioChain, pre- ex-
tracted from the following human tissues: liver (Cat. #S1234149, donor ID NB0030, male, 30
years old) and brain (Cat. #S1234096, donor ID H13126N, male, 26 years old.).
Whole Genome Sequencing and Analysis
Whole genome libraries were constructed using the Illumina TruSeq DNA PCR-Free LT Sam-
ple Prep Kit (Set A, Illumina, Cat. #FC-121-3001). 350bp insert libraries were prepared from
both samples using 1μg of gDNA according to the manufacturers protocol (Low Sample Proto-
col, Illumina, Part #: 15036187). The final libraries were quality checked using the BioAnalyzer
High Sensitivity DNA Kit (Agilent, Cat. #5067–4626), and were quantified by qPCR (KAPA
BioSystems, Cat. #KK4824). The libraries were pooled in equimolar ratios, and sequenced
twice as 100bp paired-end Illumina HiSeq 2500 Rapid runs. R2 reads from the first sequencing
run were excluded due to low quality values. All remaining sequence data was merged for
alignment and analysis.
Whole genome sequence (WGS) data was aligned using BWA v0.6.2-r126-tpx [47] with de-
fault parameters for both the aln, sampe (for the mate-pair data) and samse (for the fragment
data) commands. Alignment files were transformed into BAM files and indexed using SAM-
Tools v0.1.17 [48]. SNPs were called using qSNP v1.0 [49] with the following approach: WGS
aligned reads were filtered for PCR duplicates, and only those with an alignment length greater
than 34bp (CIGARM> = 34), an MDmismatch tag< = 4, and an SM tag value> 10 included
for SNP calling. A SNP was called as heterozygous using heuristic rules as follows: if the alter-
nate allele count was greater than three reads when the total read depth was 12 or less, or great-
er than four reads when the total read depth was between 13 and 30, or at least 25% of the
reads when there were 31 or more reads present at that location. VCF files for de novo called
SNPs are provided in S2 Dataset.
Indels were called with Pindel version 0.2.4s [50] using default parameters. Only small in-
sertions and deletions (< 200bp) were kept for analysis. Any putative indel contiguous with or
embedded within a homopolymer of seven or more bases, or overlapping a known simple re-
peat or satellite region defined by RepeatMasker (A.F.A. Smit, R. Hubley & P. Green; http://
repeatmasker.org) was removed from the analysis. Indels were called as heterozygous if the
number of supporting reads (those containing the insertion or deletion) divided by the number
of informative reads (high quality alignments) was between 0.2 and 0.7. Indel calls are provided
in S2 Dataset.
Microarray-based SNP genotyping
Samples were genotyped using the HumanOmni1M-QuadBeadChip. Briefly, 200ng of genomic
DNA per sample was whole-genome amplified and hybridized to the chip as per manufactur-
er’s instructions (Illumina, San Diego CA). SNP arrays were scanned on iScan and data was
processed using the Genotyping module (v1.8.4) in GenomeStudio (v2010.3). Where possible,
SNP coordinates were converted from human genome v18 to human genome v19 using the
UCSC LiftOver tool (http://genome.ucsc.edu/cgi-bin/hgLiftOver). Any SNPs with ambiguous
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sex chromosome positions (chrXY), or with a GC score less than 0.7, were excluded from
analysis.
SNP imputation and haplotype phasing
All SNPs with matching genotypes from both the WGS and SNP array were categorized as
high confidence and used for haplotype phasing. High confidence SNPs were filtered to include
only those with a minor allele frequency greater than or equal to 0.05. SNP imputation and
haplotype phasing is most effective when using more related individuals, such as those of the
same ethnicity. Phased haplotype data for 629 individuals were downloaded on April 12, 2012
from the MaCH website (http://www.sph.umich.edu/csg/abecasis/MACH/download/1000G-
2010-08.html). In order to establish the ethnicity of the two samples, all chromosome 22 high
confidence SNPs common with the 1000 genome data were extracted and encoded as either
heterozygous or homozygous, then used to generate a principal component analysis plot using
the mixOmics [51] R package invoking commands ‘pca.tune’ then ‘pca’ with parameters
‘ncomp = 3, center = TRUE, scale. = TRUE’. Both samples were determined to be Asian based
on the proximity of these samples to clear clusters of individuals of known Asian ethnicity (S19
Fig). SNPs were then imputed and haplotypes phased based on the appropriate ethnicity subset
of 1000 genome data using the software MaCH (v1.0.18.c) [52], with parameters ‘–quality—
compact—autoFlip—mle—mldetails—greedy—phase—states 500—rounds 50’. All imputed
SNPs were cross-checked against WGS data, and only those with matching genotypes and
passing the heuristic tests described in the Whole Genome Sequencing and Analysis section re-
tained for ASE testing.
RNA library construction and sequencing
Ribosomal depletion and RNA library construction was performed using Truseq Stranded Total
RNA kit with Ribo-Zero Human/Mouse/Rat Set A (Illumina, Cat. #RS-122-2201). Two techni-
cal replicates were prepared from both liver and brain RNA samples with 1μg of total RNA used
as starting material. The library preparations were performed according to the manufacturer's
protocol (Truseq Stranded Total RNA Sample Prep Guide, Illumina Part # 15031048) with
minor modifications to the fragmentation and the number of PCR cycles. After the addition of
Elute, Prime, Fragment High Mix to the ribosomal RNA-depleted RNA, samples were incubated
on ice and followed immediately by first strand synthesis. The number of PCR cycles used to
amplify the final libraries was decreased from 15 to 8 in order to increase library complexity.
The final cleaned libraries were quantified using the Bioanalyzer High Sensitivity DNA Kit (Agi-
lent, Cat. #5067–4626).
All the RNA libraries were indexed allowing sequencing of multiple samples on one slide.
All four libraries were pooled together in an equimolar ratio and sequenced as 100 bp paired-
end Illumina HiSeq 2500 Rapid run.
RNA-seq alignment and personalised BAM construction
Personalised haplotype reference genomes were constructed from phased and WGS verified
heterozygous and homozygous alternate SNPs using the vcf2diploid.pl tool [28]. As we did not
know the specific parent of origin for our samples, but we did have phased haplotype informa-
tion, haplotype A was arbitrarily assigned maternal, and haplotype B paternal. RNA-seq data
was aligned to each personalised haplotype reference and the universal reference with the pack-
age tophat2 v2.0.6 [53], using the Ensembl v71 gene model, with the following parameters:
‘—b2-very-sensitive—read-realign-edit-dist 0—b2-N 1—library-type fr-unstranded’.
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Alignments were merged using custom written software (available on request). This soft-
ware selects the most optimal alignments from all three alignment sets (maternal, paternal and
universal). Alignments were compared in pairs, with the pair of alignments with the smallest
sum of edit distances (SAM tag NM values) chosen and retained in the final BAM file. In the
case of a tie, the universal alignments were selected. An alignment that produced a successfully
mapped read pair was selected over one producing one or more unmapped reads. In the case of
multi-mapped reads, the alignment with the smallest edit distance was used. No discrimination
on the number of multi-mapped reads was made regarding selection of read alignment sets. All
alignments were tagged with their origin (maternal, paternal or universal) using the custom
SAM tag ZR:Z:<origin>, allowing for identification of the read origin once they are written to
the BAM file.
Following BAM construction, alignments were filtered for PCR duplicates using the picard
v1.88 MarkDuplicates utility (http://picard.sourceforge.net/). Alignments were further filtered
to remove multi-mapped reads, reads with low mapping quality (MAPQ< 9) and all reads
aligning to the mitochondrial chromosome (to expedite later analysis). All subsequent analyses
were performed on these modified BAM files.
Expression calculations
Gene expression was quantified using custom scripts by summing the total number of R1 frag-
ments with start positions between annotated Ensembl v71 genic boundaries, then calculating
the reads per kilobase per million mapped reads (RPKM, [22]). Isoform expression was quanti-
fied using cufflinks v2.0.2 [54] on the same BAM files with parameters ‘-G<file>-v—no-
update-check-M <file>-u-b<file>—library-type fr-unstranded—max-bundle-frags 1000000
<file>‘, where the mask file contained all Ensembl v71 rRNA genes, the reference was hg19,
the GTF file was Ensembl v71.
Quantification of SNP ASE
Allelic expression from RNA-seq reads at all heterozygous SNPs was counted using the mpi-
leup command in Samtools v0.1.17 [48] with parameters ‘-A B Q 0 M 100-d 1000000’. Only
SNPs with at least 10 unique reads were considered for further analysis.
For testable SNPs the fraction of reads containing the reference allele was calculated. All
SNPs were then binned by ordered genotype (i.e. the specific reference—variant combination),
and the median of all observed SNP reference fraction values for each genotype bin calculated
for each library, as described recently [16]. In addition to calculating reference fraction values,
the probability of allelic imbalance for each SNP was calculated using a simple two-sided bino-
mial test, with the expected probability set to the appropriate observed median reference frac-
tion for that SNPs’ ordered genotype. Any testable SNP with reference fraction outside the
median reference fraction +- 0.15 and a probability of imbalance< = 0.05 (two-sided binomial
test), was classified as ASE.
Quantification of Genic ASE
All testable SNPs passing alignment quality control were grouped by genic boundaries defined
by Ensembl v71 annotations. Using the phased haplotype information obtained during SNP
imputation (see above), allelic counts for each SNP for both haplotypes were summed indepen-
dently. The probability of the observed allelic ratio was calculated using a two-sided binomial
test and used to rank genes from most imbalanced to least imbalanced.
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Supporting Information
S1 Fig. Proportion heterozygosity for imputation reference data set and samples in this
study. Brain and Liver samples have lower proportion heterozygosity than the mean of the ref-
erence data set. These proportions were consistent (slightly lower than the mean) with all sam-
ples from the 1000G reference data set used for imputation (downloaded on April 12, 2012
from the MaCH website http://www.sph.umich.edu/csg/abecasis/MACH/download/1000G-
2010-08.html).
(PDF)
S2 Fig. Gene expression correlations between replicates and tissues. (A) Correlations be-
tween RPKM gene expression values for brain sample replicate one against replicate two, (B)
liver replicate one against replicate two, and between replicates for difference tissues; (C) repli-
cate one brain against liver and (D) replicate two brain against liver. Both libraries from the
same tissues are sourced from the same starting RNA.
(PDF)
S3 Fig. Comparison of allelic expression reference fraction for diploid and universal align-
ment methods. (A) Density plot shows improvement of reference fraction for diploid align-
ment (blue, fraction = 0.503) compared to universal method (red, fraction = 0.516). (B)
Boxplot of reference fractions for diploid and universal alignment methods shows improve-
ment in mean reference fraction for diploid against universal alignment methods.
(PDF)
S4 Fig. Proportion of ASE SNPs binned by proximity to unphased heterozygous de novo
SNVs. An increase in likelihood of SNPs being classified as ASE (above the average ASE classi-
fication rate, indicated by the dotted line) is observed as far away as 10kb of both SNPs (A) and
indels (B). This suggests that polymorphisms not included in the phased haplotypes (nor used
in the diploid genome construction) affect the alignment at a much greater distance from the
testable SNP than the length of a read (100bp), possibly due to spliced reads spanning a longer
genomic distance. Alternatively, this result may indicate that SNPs in areas of high polymor-
phism may be more likely to be ASE.
(PDF)
S5 Fig. Overlap between SNPs removed for either SNV proximity or alignability. SNPs with
imperfect alignability typically do not have proximal indels nor multiple proximal other SNPs.
Additionally, SNPs with large changes in reference fraction (+- 0.15) also do not tend to fall
into these categories. These mutually exclusive attributes of SNPs indicate that when testing for
ASE multiple alignment quality control mechanisms are necessary.
(PDF)
S6 Fig. Comparison of imputation R2 values with proportion of ASE classification, propor-
tion heterozygosity, and proportion of WGS verification status. (A) Proportion of all test-
able SNPs classified as ASE binned by R2 values. Poorer R2 values have higher likelihood of
being called ASE. (B) Proportion of all testable SNPs classified as ASE after removing SNPs
with alignment confounders, indicating substantial reduction in ASE SNPs with poor R2 val-
ues. (C) Total number of SNPs failing WGS verification binned by R2 values. SNPs with lower
R2 values make up the highest number of SNPs failing WGS verification, and SNPs with high
R2 make up a large proportion also. (D) Proportion of all SNPs failing WGS verification,
binned by R2 values. (E) Proportion of WGS verified heterozygous SNPs binned by R2 values.
(F) Proportion of SNPs heterozygous SNPs failing WGS verification, binned by R2 values.
(PDF)
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S7 Fig. Smoothed scatter plots of imputation R2 values plotted against DNA and RNA ref-
erence fractions. (A) DNA reference fraction plotted against imputed R2 values for all WGS
verified heterozygous SNPs, indicating an average reference fraction of 0.5, consistent with true
heterozygosity. (B) Smoothed scatter plot of DNA reference fraction against imputed R2 value
for all SNPs imputed as heterozygous, but failing WGS verification. (C) Smoothed scatter plot
of RNA reference fraction against imputed R2 values for all ASE testable SNPs (WGS verified
heterozygous, and RNA-seq coverage> = 10 PCR de-duplicated reads).
(PDF)
S8 Fig. SNPs with perfect R2 values proximal to SNVs are more likely to be ASE. Figure is a
recreation of Fig 2, excluding all SNPs with an R2 value< 1. (A) SNPs binned by genomic dis-
tance to nearest heterozygous indel. (B) SNPs binned by nearest heterozygous un-phased de
novo called SNP. (C) SNPs binned by the number of proximal heterozygous SNPs. (D) SNPs
binned by genomic alignability. SNPs with perfect R2 values are confounded by proximal SNVs
and poor alignability.
(PDF)
S9 Fig. Proportion of ASE SNPs with perfect R2 values binned by proximity to unphased
heterozygous de novo SNVs. Figure is a recreation of S4 Fig, excluding all SNPs with an R2
value< 1. Increased proportion of ASE classified SNPs proximal to unphased SNPs and indels
extends to a distance beyond the length of a read. Removing SNPs with R2 values< 1 slightly
reduces the distance of this confounder for indels (A), and the severity of the confounder for
unphased SNPs (B), but does not eliminate it completely in either situation.
(PDF)
S10 Fig. Binomial 95% confidence interval as a function of the number of tests (read
depth). As read depth increases the standard deviation of the binomial decreases.
(PDF)
S11 Fig. Sequence read depth correlation at testable SNPs between library replicates for (A)
liver and (B) brain.While the correlation between SNP allelic expression differed substantial-
ly, the correlation between SNP sequence depth was much stronger.
(PDF)
S12 Fig. SNP reference fraction replicate correlations with increasing read depth thresh-
olds. (A) Scatter plots for correlations show that as read depth increases, so too does correla-
tion. (B) Bar plots show the proportion of all SNPs classified as either not ASE in both
replicates, ASE in both replicates, or ASE in one or the other replicate. (C) Bar plots show pro-
portion of SNPs classified as ASE in any replicate as read depth increases. Increasing the read
depth dramatically improves correlation, but at a large cost of number of testable SNPs, and
hence power to detect ASE.
(PDF)
S13 Fig. Overlaps of ASE classified genes using different testing criteria. In all plots, genes
are only tested for ASE if they contain at least two testable SNPs. (A) Very strict testing is
achieved by classifying a gene as ASE if it contains at least one replicated ASE SNP and all
SNPs within the gene show direction of imbalance concordant with the haplotype or (C) any
direction. (B) Less stringent testing is shown for genes when they can contain SNPs of which
none are classified as ASE (but may still be slightly imbalanced), but are still concordant in im-
balance direction, or (D) with any direction of imbalance. The most optimal parameters to
maximize specificity, sensitivity and overlap between replicates are shown in panel (C).
(PDF)
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S14 Fig. SNP ASE testability and intersection of SNP ASE Status. Of all SNPs testable in
both replicates, less than 13.47% were testable in both tissues (top). Of these SNPs, a tiny per-
centage (0.39%; n = 8), were classified as ASE in both tissues (bottom).
(PDF)
S15 Fig. Gene ASE schematic for (A) ERAP2 and (B) GSTA2 showing strong allele-specific
expression for both genes. Red circles are exonic SNPs and blue circles intronic SNPs. SNP
colour is proportional to probability of ASE (darker is more significant). Error bars represent
the 95% binomial confidence interval (Pearson-Klopper). The gene model at the top shows the
exonic (red) and intronic (blue) SNPs, the black sticks above these represent the read depth
(min height represents 10 reads, max height 200 or more reads). Isoform models below are or-
dered by expression (top highest), and coloured by expression (darker is higher expressed).
Only exonic SNPs are shown on transcripts, and only transcripts with at least one testable ex-
onic SNP are drawn. Exon lengths are drawn at log2, and intron lengths at log10.
(PDF)
S16 Fig. Proportion of SNPs with perfect R2 imputation values (R2 = 1) annotated within
transcript features categorised as ASE. Dashed black line represents the average proportion
of all ASE SNPs. SNPs falling within intergenic regions (p< 0.002) are more likely to be classi-
fied ASE than SNPs falling in other regions.
(PDF)
S17 Fig. Extended allele-specific expression of gene RP11-422N16.3 antisense to Syntabulin
(SYBU). Integrative Genome Viewer (IGV [55]) screenshot where SNPs are represented as
white columns within the top six gray tracks. Three tracks for each SNP with sufficient strand-
specific expression are shown; the—log10 of binomial probability, reference fraction and hap-
lotype A fraction. These are clustered into two groups, negative strand (upper three) and posi-
tive strand (lower three). RNA-seq data are shown below these tracks (red reads are
transcribed from the positive strand, and blue from the negative). Gene models below the
RNA-seq show gene start, end, and exon structure. A large block of 36 SNPs is observed on the
positive strand showing concordant direction of allelic expression imbalance, initiating anti-
sense to SYBU at the RP11-422N16.3 locus and running downstream for approximately 50kb.
This extended un-annotated transcription, observed in the liver sample, is likely to show allelic
expression imbalance along the entire transcript, however only the window of 14kb contains
heterozygous SNPs and is testable.
(TIF)
S18 Fig. Un-annotated allele-specific expression antisense to Dihydroorotate dehydroge-
nase (DHODH). Integrative Genome Viewer (IGV [55]) screenshot where SNPs are repre-
sented as white columns within the top six gray tracks. Three tracks for each SNP with
sufficient strand-specific expression are shown; the—log10 of binomial probability, reference
fraction and haplotype A fraction. These are clustered into two groups, negative strand (upper
three) and positive strand (lower three). RNA-seq data are shown below these tracks (red reads
are transcribed from the positive strand, and blue from the negative). Gene models below the
RNA-seq show gene start, end, and exon structure. 22 SNPs show strong evidence of ASE on
the negative strand (top tracks). This allele-specific expression initiates downstream of and
antisense to DHODH, and proceeds for a distance of approximately 32kb. This un-annotated
antisense transcription also displays evidence of splicing indicating post-transcriptional
regulation.
(TIF)
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S19 Fig. PCA plot of samples from this study and the 1000 Genome Project pilot data. The
two samples used in this study cluster with the Asian samples, indicating they are of Asian
descent.
(PDF)
S1 Table. Number of genotyped, imputed, and quality control passing heterozygous SNPs
for each sample.
(XLSX)
S2 Table. Number of PCR de-duplicated, uniquely aligning R1 reads per library and align-
ment method.
(XLSX)
S3 Table. Read mapping differences at expressed heterozygous SNPs.
(XLSX)
S4 Table. SNP ASE classification differences between diploid and universal alignment
methods.
(XLSX)
S5 Table. Number of SNPs removed from the analyses due to proximity to SNVs.
(XLSX)
S6 Table. Number of SNPs classified as ASE in each replicate, and the overlaps between rep-
licate classifications as minimum read depth increases.
(XLSX)
S1 Dataset. Data for all testable SNPs and genes, with allele read counts, depth, reference
fractions and imbalance probabilities.
(GZ)
S2 Dataset. VCF files for un-phased SNPs and indels.
(GZ)
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